C-Mer Eye Care Holdings Ltd

HKSE:03309 (Hong Kong)   Ordinary Shares
HK$ 2.93 (+0.69%) Jun 7
58.60
P/B:
1.99
Market Cap:
HK$ 3.68B ($ 470.90M)
Enterprise V:
HK$ 3.46B ($ 442.80M)
Volume:
490.00K
Avg Vol (2M):
944.77K
Volume:
490.00K
Avg Vol (2M):
944.77K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for C-Mer Eye Care Holdings Ltd ( ) from 2018 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. C-Mer Eye Care stock (HKSE:03309) PE ratio as of Jun 07 2024 is 58.6. More Details

C-Mer Eye Care Holdings Ltd (HKSE:03309) PE Ratio (TTM) Chart

To

C-Mer Eye Care Holdings Ltd (HKSE:03309) PE Ratio (TTM) Historical Data

Total 1222
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
C-Mer Eye Care PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-07 58.6 2024-04-03 54.4
2024-06-07 58.6 2024-04-02 54.4
2024-06-06 58.2 2024-03-28 56.6
2024-06-05 60.0 2024-03-27 57.8
2024-06-04 60.2 2024-03-26 57.8
2024-06-03 58.6 2024-03-25 58.0
2024-05-31 59.0 2024-03-22 58.4
2024-05-30 59.6 2024-03-21 59.6
2024-05-29 60.0 2024-03-20 59.8
2024-05-28 60.4 2024-03-19 60.2
2024-05-27 59.6 2024-03-18 61.4
2024-05-24 59.8 2024-03-15 61.8
2024-05-23 62.0 2024-03-14 63.8
2024-05-22 62.6 2024-03-13 64.4
2024-05-21 61.8 2024-03-12 59.8
2024-05-20 64.6 2024-03-11 57.6
2024-05-17 65.2 2024-03-08 57.2
2024-05-16 63.6 2024-03-07 57.6
2024-05-14 64.0 2024-03-06 59.6
2024-05-13 63.4 2024-03-05 59.2
2024-05-10 62.2 2024-03-04 60.8
2024-05-09 63.2 2024-03-01 60.4
2024-05-08 60.6 2024-02-29 61.0
2024-05-07 61.4 2024-02-28 60.4
2024-05-06 60.4 2024-02-27 60.8
2024-05-03 61.0 2024-02-26 59.8
2024-05-02 61.2 2024-02-23 60.8
2024-04-30 59.4 2024-02-22 59.8
2024-04-29 60.2 2024-02-21 61.2
2024-04-26 59.4 2024-02-20 61.4
2024-04-25 58.2 2024-02-19 58.2
2024-04-24 57.0 2024-02-16 56.8
2024-04-23 56.0 2024-02-15 55.2
2024-04-22 56.4 2024-02-14 54.0
2024-04-19 56.4 2024-02-09 55.0
2024-04-18 57.8 2024-02-08 54.4
2024-04-17 58.0 2024-02-07 53.8
2024-04-16 57.2 2024-02-06 54.0
2024-04-15 58.4 2024-02-05 52.2
2024-04-12 58.0 2024-02-02 50.6
2024-04-11 57.8 2024-02-01 53.0
2024-04-10 56.2 2024-01-31 52.8
2024-04-09 56.0 2024-01-30 55.6
2024-04-08 54.6 2024-01-29 57.6
2024-04-05 54.4 2024-01-26 59.4

C-Mer Eye Care Holdings Ltd (HKSE:03309) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include the HK medical business, Sales of medical consumables, Mainland China ophthalmic business, and Mainland China dental business. It generates a vast majority of its revenue from the provision of the HK medical business.